Identification of periprosthetic joint infection after total hip arthroplasty  by Lee, Kyung-Jae & Goodman, Stuart B.
Journal of Orthopaedic Translation (2015) 3, 21e25Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /ees.elsevier .com/jotREVIEW ARTICLEIdentification of periprosthetic joint
infection after total hip arthroplasty
Kyung-Jae Lee a,b,*, Stuart B. Goodman ca Department of Orthopaedic Surgery, Keimyung University, Daegu, South Korea
b Pain Research Center, Keimyung University, Daegu, South Korea
c Departments of Orthopaedic Surgery and Bioengineering, Stanford University, Stanford, CA, USAReceived 27 July 2014; received in revised form 20 October 2014; accepted 21 October 2014






infection* Corresponding author. Departme
Keimyung University, School of Med
Dalsung-Ro, Joong-Gu, Daegu, South K
E-mail address: oslee@dsmc.or.kr
http://dx.doi.org/10.1016/j.jot.2014.
2214-031X/Copyright ª 2014, The Aut
license (http://creativecommons.org/Summary Although total hip arthroplasty (THA) is accepted as one of the most successful
surgical procedures in orthopaedic surgery, periprosthetic joint infection after THA continues
to be one of the most devastating complications. However, accurate preoperative identifica-
tion of periprosthetic joint infection in patients presenting with joint pain or radiographic peri-
prosthetic lucencies is often difficult, even after a comprehensive work-up. The purpose of this
article is to review the diagnostic options available to improve the management and results of
this potentially catastrophic complication.
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Total hip arthroplasty (THA) is a well-accepted treatment,
providing relief of symptoms for those suffering from end-
stage hip disease such as severe osteoarthritis, post-
traumatic arthritis, developmental dysplasia, inflammatory
arthritis, and osteonecrosis of the femoral head [1e6].
Despite the high rates of long-term success, THA may
require further surgical management because of loosening,nt of Orthopaedic Surgery,




hors. Published by Elsevier (Singap
licenses/by-nc-nd/4.0/).wear (osteolysis), instability, periprosthetic fracture, and
infection [4,7]. Among these complications, periprosthetic
joint infection (PJI) remains one of the most serious and is a
key challenge to orthopaedic surgeons. In the United
States, deep PJI (subfascial extension of infection) is
currently the third most frequent indication for revision
THA, and the incidence of PJI after THA ranges from 0.3% to
2.2% [8,9]. Furthermore, PJI imposes significant physical
and psychological morbidity on patients and causes enor-
mous financial burden on both patients and society. The
sequelae of PJI can result in decreased joint function,
diminished patient quality of life, and in some cases
arthrodesis, amputation, or permanent resection arthro-
plasty [10]. The financial cost to the health care system is
estimated at US$96,166 per patient requiring revisionore) Pte Ltd. This is an open access article under the CC BY-NC-ND
22 K.-J. Lee, S.B. Goodmanarthroplasty for infection, which is 4.8 times the cost of a
primary hip arthroplasty [11]. Because of these reasons,
significant effort has been made in improving the diagnosis
and treatment of infected THA.
Management of PJI depends on accurate diagnosis and
successful treatment (eradicating the infection and main-
taining the hip function), both of which are complicated
and challenging. Despite a large number of basic and clin-
ical studies, establishing a definite diagnosis of PJI prior to
surgical intervention is still difficult [12]. Failure to accu-
rately recognize a joint infection may lead to the unin-
tended implantation of a new prosthesis into an infected
surgical site, which may cause persistent infection and
early failure of the revision arthroplasty. However, erro-
neous diagnosis of a joint infection where there is no
infection may result in unnecessary surgical procedures and
inappropriate treatment with a prolonged course of
parenteral antibiotics [7]. There is no single gold standard
diagnostic test for identification of PJI, and individual tests
have low sensitivity or specificity [13e17]. Currently the
diagnosis of PJI relies on a combination of clinical judg-
ment, preoperative hematologic testing, information ob-
tained from aspiration, and microbiologic as well as
histopathologic testing of tissue or fluid obtained at the
time of surgery [18].Clinical judgment (history and physical
examination)
Meticulous evaluation of the patient’s medical and surgical
history as well as comprehensive physical examination is an
important screening tool for PJI and helps to guide the
subsequent diagnostic evaluation. Identification of the pa-
tient’s comorbidities could raise the possibility of PJI as the
cause of pain or failure, so precise history taking concern-
ing specific risk factors (diabetes mellitus, use of cortico-
steroids, obesity, rheumatoid arthritis and other
inflammatory arthritis, chronic renal failure, malnutrition,
and immunocompromised state) is very important [9].
Previous wound healing problems, prolonged perioperative
antibiotic administration, rapid unexplained prosthetic
failure, or repeated surgery are historical clues often
associated with PJI [18e21]. Clinical symptoms and signs
are not always reliable, and PJI often occurs without overt
local or systemic manifestations. However, subtle findings
on physical examination, such as wound erythema or fluid
collections, may be present in acute or chronic infection
[22]. The presence of an active or healed sinus tract
communicating with the joint space is also diagnostic for
PJI [21].Imaging evaluation
Imaging modalities provide noninvasive tests for PJI of the
hip. Plain radiographs are widely used in the initial evalu-
ation of painful THA and can detect periprosthetic frac-
tures, changes in implant position, osteolysis, and findings
consistent with PJI. However, Tigges et al [23] retrospec-
tively reviewed radiographs of a known cohort of infected
THAs and found that 50% of radiographs in this cohort werenormal. Twenty percent of radiographs in their study
showed abnormalities that are commonly associated with
aseptic loosening and 10% of radiographs showed nonspe-
cific findings. Furthermore, findings more commonly asso-
ciated with infection, such as a periosteal reaction and
rapidly developing periprosthetic radiolucencies, were
identified in only 20% of radiographs. However, radiographs
are useful in the initial evaluation of painful and potentially
infected THA because they can detect new changes highly
suggestive of PJI that can guide further diagnostic testing
[23].
Computed tomography (CT) and magnetic resonance
imaging (MRI) more often are being used as preoperative
planning tools for revision procedures and the evaluation
of painful THAs [24] because of the technical advance-
ments that reduce metallic image artefact due to beam
hardening and magnetic susceptibility. However, CT and
MRI have not been conclusively shown to provide an ac-
curate diagnosis of PJI [13]. Periostitis seen on CT in as-
sociation with THAs is extremely sensitive (100%) for PJI
but poorly specific (16%). For MRI, concomitant joint
distention and soft-tissue fluid collections around a THA
increase specificity of periostitis as a marker for PJI to
87%, but MRI signal characteristics and findings that can
distinguish aseptic loosening from PJI are not known [24].
At this time, CT and MRI are not first-line imaging evalu-
ation tools for potential PJI after THA.
The role of radionuclide imaging and 18F-fludeoxyglucose
positron emission tomography (FDG PET) in evaluating pa-
tients for PJI has expanded. Levitsky et al [25] reported
that bone marrow scintigraphy showed sensitivity of 33%,
specificity of 86%, positive predictive value (PPV) of 30%,
and negative predictive value (NPV) of 88% when used to
confirm or exclude the presence of PJI. In a more recent
study, Basu et al [26] reported sensitivity of 38.5%, speci-
ficity of 95.7%, PPV of 71.4%, and NPV of 84.6% with labeled
leukocyte/99mTc-sulfur colloid bone marrow imaging. FDG
PET has also shown reasonable results for diagnosis or
exclusion of PJI. When evaluating painful prosthesis for
infection, Chryssikos et al [27] reported that PDG PET
showed 95% sensitivity, 93% specificity, 80% PPV, and 98.5%
NPV. In a study of 134 patients with THA examined with FDG
PET, Basu et al [26] reported values of 81.8%, 93.1%, 79.4%,
and 94.0%, respectively, and concluded the diagnostic
performance of FDG PET scan in detecting infection in
painful hip and knee prostheses is optimal for routine
clinical application. On the basis of these results, radio-
nuclide imaging appears to have a role in detecting the
presence or absence of PJI, but availability, timeliness, and
cost of these advanced imaging modalities have limited
their widespread use.Blood laboratory markers
When suspicion of PJI exists, obtaining a white blood cell
(WBC) count, erythrocyte sedimentation rate (ESR), and
C-reactive protein (CRP) concentration is the first step in
the work-up. An ESR > 30 mm/h or a serum CRP >
1.0e3.5 mg/L is suggestive of PJI [16,28]. When taken
together, a positive ESR or positive CRP provides a sensi-
tivity and specificity of 94e98% and 59e77%, respectively
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because they are highly sensitive but less specific
[16,30,31], and these markers are also affected by age,
sex, and medical comorbidities of the patient. For
example, the WBC count is rarely elevated in the presence
of chronic PJI [32], and the CRP level can be elevated for
approximately 30e60 days in the immediate postoperative
period [33], limiting its predictive value. Greidanus et al
[28] reported in their Level 1 study of 207 consecutive
total knee arthroplasty revisions that if both the ESR and
CRP level were normal, the probability of PJI was 3%. By
contrast, the ability of these tests to confirm the presence
of PJI was less optimal because when both ESR and CRP
level were elevated, the PPV for PJI was only 84%. The
authors concluded that when both ESR and CRP level are
normal, a low likelihood of PJI exists, but when either ESR
or CRP level is elevated, further testing for PJI is indi-
cated. Recently published studies have suggested that
interleukin-6 (IL-6) may be a more accurate marker for
infection than the CRP level or ESR [33e35]. IL-6 is pro-
duced by stimulated monocytes and macrophages, and
induces the production of several acute-phase proteins,
including CRP. The serum IL-6 level in normal individuals is
approximately 1 pg/mL, and it can increase to 30e430 pg/
mL for as long as 3 days following total joint arthroplasty
[34,36]. IL-6 peaks at 2 days after uncomplicated arthro-
plasty and rapidly returns to a normal level thereafter.
CRP is an acute-phase reactant that is produced by the
liver in response to inflammation, infection, and
neoplasm. CRP levels are elevated to their peak values
2e3 days after surgery and return to normal approxi-
mately 3 weeks after surgery. IL-6 in serum showed
significantly higher levels in the PJI group, compared to
cases with aseptic loosening and controls, with a speci-
ficity of 58.3% and a sensitivity of 79.5% at a cutoff value
of 2.6 pg/mL; with a cutoff > 6.6 pg/mL, the specificity
increased to 88.3% [35]. Berbari et al [33] reported in
their systematic review that a diagnostic odds ratio of
inflammatory blood laboratory levels as markers of PJI
showed 314.7 pg/mL (95% confidence interval,
113.0e876.8) for IL-6, 13.1 mg/L (95% confidence interval,
7.9e21.7) for CRP, 7.2 mm/h (95% confidence interval,
4.7e10.9) for ESR, and 4.4  103/mL (95% confidence in-
terval, 2.9e6.6) for the WBC count and they concluded
that the diagnostic accuracy for PJI was best for IL-6,
followed by CRP level, ESR, and WBC count. More
recently, several other markers such as procalcitonin,
tumour necrosis factor-alpha, lipopolysaccharide-binding
protein, and CD64 were also evaluated as a marker of PJI
but showed inconsistent results [12,34,37].Joint aspiration and synovial fluid analysis
Joint aspiration to identify infection prior to revision sur-
gery is recommended by several authors [38e41]. Although
the indications for routine versus selective use of joint
aspiration prior to having revision surgery are not clear, in
the event of elevated ESR or CRP levels, continued suspi-
cion of acute or chronic PJI, an aspiration of the joint are
warranted. Furthermore, the use of aspiration and subse-
quent synovial fluid analysis such as synovial fluid WBCcount with analysis of percentage of polymorphonuclear
(PMN) cells has gained popularity as a reliable method for
differentiating PJI from aseptic THA failure. A lower cut-off
value should be used for PJI as compared to native joints,
because of the lower virulence of microorganism in PJI and
the presence of a biofilm. Schinsky et al [42] studied 201
total hip revisions, in which 55 revisions were for septic
etiology, and found that synovial WBC count > 4200 cells/
mL had a sensitivity, specificity, and accuracy of 84%, 93%,
and 90%, respectively. They also found that if the per-
centage of PMN cells was > 80% of the total number of
mononuclear cells in the aspirate, the diagnosis of PJI had
a sensitivity, specificity, and accuracy of 82%, 83%, and
83%, respectively. Synovial fluid WBC count can be espe-
cially useful for identifying or excluding PJI in time-
sensitive clinical scenarios. In the case of well-
functioning hip replacements that become acutely pain-
ful, or the presence of systemic sepsis with unclear cause,
the possibility of THA infection often needs to be excluded
in an accurate and expedient manner. In these clinical
situations, aspiration and synovial fluid WBC count with or
without associated PMN percentage calculation is the
fastest and most accurate means by which to confirm or
exclude PJI [22]. Hip joint aspiration can be performed
under fluoroscopic or ultrasound guidance. Repeat aspira-
tion is indicated if a false-negative or false-positive result
is suspected based on the presence of clinical or radio-
graphic evidence of infection, and may also indicated when
a positive culture is based on liquid medium only in the
absence of any other evidence of infection. Combining the
results of initial and repeat aspiration, sensitivity has been
reported to be 100% [43]. Relatively high percentages (32%)
of dry or inadequate joint aspirates have been reported
[40]. In this situation, repositioning the needle deeper to
the inferomedial aspect of the femoral neck under fluoro-
scopic control, injection of 10 mL normal saline (without
bacteriostatic additive) and repeat aspiration, or slow
manipulation (repeated flexion, internal rotation combined
with adduction) of the hip can be attempted. The sensi-
tivity of the culture from hip aspiration with saline injec-
tion is comparable to that without saline injection [41].
More recently, Deirmengian et al [44,45] reported useful-
ness of synovial fluid biomarkers for the diagnosis of PJI.
They found that synovial fluid alpha-defensin test alone
demonstrated a sensitivity of 97% and a specificity of 96%
for the diagnosis of PJI and if it is combined with synovial
fluid CRP level, sensitivity and specificity of the test were
97% and 100%, respectively.Microbiologic and histopathologic examination
of tissues
Traditionally, joint aspiration has been performed to obtain
fluid for bacterial culture, which then determined the
presence or absence of PJI. However, new investigations
seeking to define the utility of cultured synovial fluid in
confirming or excluding PJI have shown a wide range of
sensitivity (50e86%) and specificity (88e97%) as well as a
modest to high incidence of false-positive culture results
(3e16%; Table 1) [19,39,40,46e48]. To increase the yield of
the joint aspirate, specimens should be sent for analysis
Table 1 Result of joint aspiration and culture in the diagnosis of periprosthetic joint infection after total hip arthroplasty.
Study Publication year Number of aspirations Sensitivity (%) Specificity (%)
Ali et al [40] 2006 77 82 91
Barrack and Harris [46] 1993 291 60 88.3
Fehring and Cohen [39] 1996 166 50 88
Lachiewicz et al [19] 1996 156 85 97
Spangehl et al [47] 1999 180 86 94
Williams et al [48] 2004 273 80 94
24 K.-J. Lee, S.B. Goodmanimmediately and prolonged culture for 2 weeks or longer to
help identify PJI that would otherwise remain undetected
[41]. The culture medium may also affect the sensitivity.
Using a blood culture bottle to inoculate the joint aspirate
can improve the detection of fastidious or slow-growing
organisms, the ability to detect more pathogens and
fewer contaminants, and improve the sensitivity for
detecting microorganisms [41].
Analysis of frozen sections from intraoperative tissue
sampling can be used as another diagnostic tool for PJI
after THA. Tsaras et al [7] reported that frozen sections can
be used as a valuable part of the diagnostic work-up for
patients undergoing revision arthroplasty, especially when
the potential for infection remains after a thorough pre-
operative evaluation. The threshold for diagnosis of PJI
ranges from 5 neutrophils to 10 neutrophils per high-
powered field. However, the accuracy of preparation and
interpretation of frozen sections can be highly operator
dependent [29].
Conclusion
As the number of primary THAs has increased in the United
States over the past decade, the incidence of PJI is also
growing disproportionally [8]. Failure to recognize this
complication results in prolonged patient morbidity and
disability, as well as the performance of surgical in-
terventions that have an unacceptably low probability of
success. At this time, the diagnosis of PJI depends on a
combination of clinical judgment and several diagnostic
modalities [18]. The first evaluation for PJI after THA is a
high index of suspicion, and a thorough history and physical
examination and appropriate radiographic imaging [22].
Blood laboratory markers such as ESR and CRP level are
extremely useful for ruling out PJI and should be used as
first-line screening tests [28]. Properly performed joint
aspiration with synovial fluid WBC count, PMN cell per-
centage, and culture are the cornerstones of the diagnostic
algorithm for confirmation or exclusion of PJI after THA
[22,42]. Although identification of PJI after THA is difficult,
an evidence-based and algorithmic approach can improve
the accuracy of diagnosis for this very serious but poten-
tially treatable complication.
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